Asset Details
Do you wish to reserve the book?
Paving the way to improve therapy for Myeloproliferative Neoplasms
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Paving the way to improve therapy for Myeloproliferative Neoplasms
Do you wish to request the book?
Paving the way to improve therapy for Myeloproliferative Neoplasms
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Paving the way to improve therapy for Myeloproliferative Neoplasms
2022
Overview
Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in
Nature Communications
, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that mediate treatment resistance.
